It has been reported that LIPT1 is upregulated in melanoma and is an independent favorable prognostic indicator.[13] Therefore, LIPT1 may play a similar role in inhibiting tumor progression in NSCLC. This evidence concerns the gene LIPT1 and neoplasm.